Arai T, Fukuhisa K, Takeda E, Murata M, Kasamatsu T, Tsunematsu R, Masubuchi K, Fukuda T, Noguchi H, Chihara T
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1506-13.
Radiation-induced cancer has been epidemiologically investigated in occupational or atomic radiation exposure cases. These is also a need to clarify the risk in the case of radiotherapeutical exposure. In this study, therefore, cases of post-irradiated uterine carcinoma which was well cured and followed up over a long term were selected for statistical analysis of radiation-induced cancer in the medical division.
A total of 19,384 patients with uterine carcinoma at seven institutions in Japan were registered on a computer system at the NIRS and were statistically analyzed. Of these, 6,655 patients were treated by surgical procedure alone, 4,310 were given a combined treatment modality of radiation and surgery, 8,419 were treated by radiation alone between 1960 and 1978. Radiation-induced cancer was defined according to the following categories: Secondary cancer was developed within the irradiated field. Time interval was over 5 years after the initial irradiation (leukemia was over 2 years). The cancer had a different histological type to the original one. A total of 43 patients with induced cancer were observed, namely: 14 with rectal cancer, 8 with leukemia, 6 with uterine corpus cancer, 4 with urinary bladder cancer, 3 with osteosarcoma or uterine sarcoma, 2 with sigmoid colon cancer or malignant fibrous histiocytoma, and 1 with ovarian cancer, respectively.
Rectal cancer, leukemia and urinary bladder cancer were initially analyzed, because their expected values were easily estimated from the basic data. A total of 8,333 patients (43,418 person-years) from 7 institutions were considered. Their average follow-up period was 10.2 years after treatment. 1) Rectal cancer: Observed value (O) = 14, expected value (E) = 7.83, O/E = 1.79, 95% confidence interval of O/E ratio (CI) = 0.98-2.99, there was no significant difference. 2) Leukemia: O = 8, E = 3.78, O/E = 2.12, CI = 0.91-4.18, no significant difference. 3) Urinary bladder cancer: O = 4, E = 2.23, O/E = 1.79, CI = 0.49-4.55, no significant difference. In other words, no significant difference was observed in the risk of occurrence of secondary cancer among the total number of irradiated patients from the 7 institutions. Since these results, however, were influenced by the accuracy of patient follow-up, the O/E ratio of double cancer in each institution was observed to check the accuracy of the follow-up and 3 institutions were selected for further analysis comprising 2,686 patients (13,588 person-years) in all. Their average follow-up period was 10.1 years.(ABSTRACT TRUNCATED AT 400 WORDS)
已对职业性或原子辐射暴露病例中的辐射诱发癌症进行了流行病学调查。对于放射治疗暴露情况下的风险也有必要加以阐明。因此,在本研究中,选择了经照射后子宫癌得到良好治愈并长期随访的病例,用于医学领域辐射诱发癌症的统计分析。
日本7家机构的总共19384例子宫癌患者在日本国立放射科学研究所的计算机系统中进行了登记,并进行了统计分析。其中,1960年至1978年间,6655例患者仅接受了手术治疗,4310例接受了放疗与手术的联合治疗方式,8419例仅接受了放疗。辐射诱发癌症根据以下类别定义:在照射野内发生了继发性癌症。时间间隔在首次照射后超过5年(白血病为超过2年)。该癌症与原发癌症的组织学类型不同。总共观察到43例诱发癌症患者,分别为:14例直肠癌、8例白血病、6例子宫体癌、4例膀胱癌、3例骨肉瘤或子宫肉瘤、2例乙状结肠癌或恶性纤维组织细胞瘤以及1例卵巢癌。
首先对直肠癌、白血病和膀胱癌进行分析,因为从基础数据中很容易估算出它们的预期值。考虑了7家机构的总共8333例患者(43418人年)。他们治疗后的平均随访期为10.2年。1)直肠癌:观察值(O)=14,预期值(E)=7.83,O/E =1.79,O/E比值的95%置信区间(CI)=0.98 - 2.99,无显著差异。2)白血病:O =8,E =3.78,O/E =2.12,CI =0.91 - 4.18,无显著差异。3)膀胱癌:O =4,E =2.23,O/E =1.79,CI =0.49 - 4.55,无显著差异。换句话说,在这7家机构的全部受照射患者中,继发性癌症发生风险未观察到显著差异。然而,由于这些结果受到患者随访准确性的影响,观察了各机构双原发癌的O/E比值以检查随访的准确性,并选择了3家机构进行进一步分析,总共2686例患者(13588人年)。他们的平均随访期为10.1年。(摘要截断于400字)